Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interferon alpha 22, pseudogene (IFNA22P) is a non-coding genetic locus present in the human genome within the type I interferon cluster, most notably on chromosome 9. Unlike protein-coding interferon alpha genes, IFNA22P does not produce a functional interferon alpha protein and does not participate in canonical biological processes such as antiviral defense or immune modulation. As a pseudogene, IFNA22P has no direct role in disease, therapeutic mechanisms, or drug interactions, and it should not be considered a therapeutic target in drug discovery or biomedical research. Sometimes pseudogenes are investigated for regulatory or evolutionary roles, but there is no evidence suggesting IFNA22P has any such established function in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon alpha 22, pseudogene (IFNA22P).